Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Primary IgA nephropathies in children.

R Habib1, I Murcia, H Beaufils

  • 1INSERM U192, Hôpital Necker, Enfants Malades, Paris, France.

Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renal transplantation in 4 patients with methylmalonic aciduria: a cell therapy for metabolic disease.

Molecular genetics and metabolism·2013
Same author

[Children and adolescents with ESRD].

Nephrologie & therapeutique·2012
Same author

Eculizumab for atypical hemolytic uremic syndrome recurrence in renal transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same author

Renal transplantation under prophylactic eculizumab in atypical hemolytic uremic syndrome with CFH/CFHR1 hybrid protein.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2012
Same author

Population pharmacokinetics and pharmacogenetics of tacrolimus in de novo pediatric kidney transplant recipients.

Clinical pharmacology and therapeutics·2009
Same author

Causes of death in pediatric systemic lupus erythematosus.

Clinical and experimental rheumatology·2009

Idiopathic IgA nephropathy, also known as Berger's disease, is a syndrome, not a single entity. Schönlein-Henoch purpura (SHP) and Berger's disease share common pathology and pathogenesis, suggesting a spectrum of IgA-associated diseases.

Area of Science:

  • Nephrology
  • Immunology
  • Pathology

Background:

  • Immunofluorescence microscopy has identified IgA nephropathy (Berger's disease) as a primary glomerular disease.
  • IgA nephropathy is the most prevalent form of glomerulonephritis globally.
  • Diagnostic criteria based solely on mesangial IgA deposits obscure the diverse clinical conditions sharing this immunopathology.

Purpose of the Study:

  • To review the clinical features of Schönlein-Henoch purpura (SHP) and IgA nephropathy in children.
  • To explore the relationship between SHP and IgA nephropathy.
  • To propose IgA nephropathy as a syndrome encompassing various clinical conditions.

Main Methods:

  • Review of clinical features of SHP and IgA nephropathy in pediatric populations.

Related Experiment Videos

  • Comparative analysis of pathology and pathogenesis between SHP and IgA nephropathy.
  • Examination of recurrence patterns post-kidney transplantation and familial occurrence.

    • Main Results:

    • SHP and IgA nephropathy share identical pathology and pathogenesis.
    • Both conditions can recur in transplanted kidneys.
    • Familial occurrence of both diseases suggests a genetic link.
    • Clinical manifestations of SHP and IgA nephropathy, though appearing distinct, are closely related.

    Conclusions:

    • IgA nephropathy should be considered a syndrome rather than a distinct entity.
    • SHP and Berger's disease are primary manifestations of this IgA nephropathy syndrome.
    • Further research into pathological mechanisms may position SHP and Berger's disease as ends of a spectrum of IgA-mediated microvascular diseases.